Reply - 03/08/11
Disclosure of potential conflict of interest: H. A. Sampson is a consultant for Allertein Therapeutics, LLC; has received research support from the Food Allergy Initiative (FAI) and the National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID); is a consultant and scientific advisor for the FAI; is a medical advisor for the Food Allergy & Anaphylaxis Network (FAAN); is a scientific advisor for the University of Nebraska–FARRP; and is 45% owner of Herbal Springs, LLC. S. H. Sicherer is a consultant for the FAI and has received research support from the NIH/NIAID. The rest of the authors have declared they have no conflict of interest. |
Vol 128 - N° 2
P. 435 - août 2011 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?